Literature DB >> 10757682

Hypoxemia is a risk factor for bone mass loss.

H Fujimoto1, K Fujimoto, A Ueda, M Ohata.   

Abstract

Time-dependent changes of bone mass in ambulant chronic respiratory failure patients 60 or more years of age were compared between those on home oxygen therapy (HOT) and those still free of HOT (non-HOT). HOT (n = 31) showed initial PaO2 of slightly greater than 60 Torr and non-HOT (n = 32) had PaO2 moderately greater than 60 Torr (64.4 Torr vs 75.1 Torr). PaCO2 in HOT was significantly higher than that of non-HOT (44.8 Torr vs 40.0 Torr). There was no difference in pulmonary function test results. The whole bone mineral density (BMD) as adjusted by age and sex was significantly lower in the HOT group than that in the non-HOT. At endpoints of the follow-up period over 2 years or more, daily bone losses in the whole BMD, whole bone mineral content, and lumber BMD were significantly more accelerated in HOT compared with non-HOT. When the Wistar rats were pair-fed and their locomotion was limited, the animal group placed for 4 weeks under hypoxic air showed a reduction in BMD as compared with the control. We suggest that hypoxemia contributes to bone mass loss.

Entities:  

Mesh:

Year:  1999        PMID: 10757682     DOI: 10.1007/s007740050087

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  16 in total

1.  COPD as an independent risk factor for osteoporosis and fractures.

Authors:  M G Adas-Okuma; S S Maeda; M R Gazzotti; C M Roco; C O Pradella; O A Nascimento; E F Porto; J G H Vieira; J R Jardim; M Lazaretti-Castro
Journal:  Osteoporos Int       Date:  2019-12-06       Impact factor: 4.507

2.  Bone mineral density and changes in bone metabolism in patients with obstructive sleep apnea syndrome.

Authors:  Rabia Terzi; Zahide Yılmaz
Journal:  J Bone Miner Metab       Date:  2015-07-24       Impact factor: 2.626

3.  Anemia and the risk of non-vertebral fractures: the Tromsø Study.

Authors:  L Jørgensen; T Skjelbakken; M-L Løchen; L Ahmed; A Bjørnerem; R Joakimsen; B K Jacobsen
Journal:  Osteoporos Int       Date:  2009-12-03       Impact factor: 4.507

4.  Haemoglobin levels are associated with bone mineral density in the elderly: a population-based study.

Authors:  Alice Laudisio; Emanuele Marzetti; Francesco Pagano; Roberto Bernabei; Giuseppe Zuccalà
Journal:  Clin Rheumatol       Date:  2008-09-03       Impact factor: 2.980

5.  Bone density and hemoglobin levels in older persons: results from the InCHIANTI study.

Authors:  Matteo Cesari; Marco Pahor; Fulvio Lauretani; Brenda W H J Penninx; Benedetta Bartali; Roberto Russo; Antonio Cherubini; Richard Woodman; Stefania Bandinelli; Jack M Guralnik; Luigi Ferrucci
Journal:  Osteoporos Int       Date:  2004-09-28       Impact factor: 4.507

6.  Bone remodelling is reduced by recovery from iron-deficiency anaemia in premenopausal women.

Authors:  Ione Wright; Ruth Blanco-Rojo; M Cristina Fernández; Laura Toxqui; Gemma Moreno; Ana M Pérez-Granados; Concepción de la Piedra; Ángel F Remacha; M Pilar Vaquero
Journal:  J Physiol Biochem       Date:  2013-06-28       Impact factor: 4.158

Review 7.  Osteoporosis in chronic obstructive pulmonary disease.

Authors:  Malay Sarkar; Rajeev Bhardwaj; Irappa Madabhavi; Jasmin Khatana
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2015-03-12

8.  Prevalence of Osteoporosis and Its Risk Factors in Men with COPD in Qazvin.

Authors:  Mahnaz Abbasi; Mohammadali Zohal; Banafsheh Atapour; Zohreh Yazdi
Journal:  Int J Chronic Dis       Date:  2016-09-27

9.  Bone Mineral Density and Hemoglobin Levels: Opposite Associations in Younger and Older Women.

Authors:  Tzyy-Ling Chuang; Malcolm Koo; Mei-Hua Chuang; Yuh-Feng Wang
Journal:  Int J Environ Res Public Health       Date:  2021-05-20       Impact factor: 3.390

10.  Implications of gender-based variabilities in bone mineral density and hemoglobin levels.

Authors:  Yumei Zhou; Shengjun Liu; Ximei Wang; Yuhan Fu; Fan Su; Lei Cao; Xiaojuan Zha; Yufeng Wen
Journal:  BMC Musculoskelet Disord       Date:  2021-07-30       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.